Sort
10,766 grants matching “checkpoint inhibitor”
Regulation of PD-L1/PD-1 immune checkpoints by cis-interactions
$360,281Enfu Hui · University Of California, San Diego · R37 · FY2020 · CA
Inhibition of Regeneration Restraining Pathways to Promote Healing
$360,250Luis Andres Garza · Johns Hopkins University · R56 · FY2023 · AR
Transcriptional and epigenetic mechanisms of immunotherapy resistance in melanoma
$360,208Kai W Wucherpfennig · Massachusetts General Hospital · P01 · FY2023 · CA
Transcriptional and epigenetic mechanisms of immunotherapy resistance in melanoma
$360,208Kai W Wucherpfennig · Massachusetts General Hospital · P01 · FY2022 · CA
Biomaterials-based Germinal Center Niches for Understanding the B Cell Maturation and B cell receptor signaling
$360,056Ankur Singh · Georgia Institute Of Technology · R01 · FY2022 · AI
Project 2: Re-directing the Sensitivity of Metastatic Castration-Resistant Prostate Cancer to Immunotherapy
$360,000Jennifer D Wu · Northwestern University At Chicago · P50 · FY2025 · CA
UNDERSTANDING THE IMMUNE BIOLOGY OF CHECKPOINT INHIBITORS TO DEVELOP NEW STRATEGIES FOR THERAPY
$360,000The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2016 · Department of the Army
A Pathway for Necrotic Cell Death
$359,923David J Shapiro · University Of Illinois At Urbana-Champaign · R01 · FY2024 · CA
Optimizing systemic immunotherapy for personalized brain metastasis treatment
$359,712Michael Lim · Stanford University · U54 · FY2022 · CA
Applying deep learning to predict T cell receptor binding specificity of neoantigens and response to checkpoint inhibitors
$359,678Tao Wang · Ut Southwestern Medical Center · R01 · FY2022 · CA
Human Biosamples Core
$359,659Elizabeth W Karlson · Brigham And Women'S Hospital · P30 · FY2021 · AR
Polo-Like Kinase 1 as a Therapeutic Target in Medulloblastoma
$359,503Rajeev Vibhakar · University Of Colorado Denver · R01 · FY2014 · NS
Paradoxical roles of tumor lymphangiogenesis on tumor immunity and implications for immunotherapy - Resubmission 01
$359,457Melody A Swartz · University Of Chicago · R01 · FY2019 · CA
The Role of Stromal Autophagy in Cutaneous Melanoma
$359,435Hilary A Coller · University Of California Los Angeles · R01 · FY2020 · CA
Characterization and Enhancement of Anti-Tumor Immune Responses in Head and Neck Cancer
$359,407Clint Allen · National Institute On Deafness And Other Communication Disorders · ZIA · FY2015 · DC
FOXD3 up-regulation and ERBB3 signaling as an adaptive response to BRAF inhibitors in melanoma
$359,385Andrew E Aplin · Thomas Jefferson University · R01 · FY2019 · CA
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
$359,168Madhav V Dhodapkar · Emory University · U54 · FY2022 · CA
The Role of Stromal Autophagy in Cutaneous Melanoma
$359,148Hilary A Coller · University Of California Los Angeles · R01 · FY2021 · CA
Ethnicity-determined T cell responses and GARP/TGFbeta1 signaling in prostate cancer
$359,138Xiaolin Zi · University Of California-Irvine · R01 · FY2025 · CA
Regulation of the Development of Trypanosoma brucei
$359,123Ching Chung Wang · University Of California, San Francisco · R01 · FY2007 · AI
Novel immunotherapeutic potential of DGKalpha inhibition for glioblastoma
$359,097Benjamin W. Purow · University Of Virginia · R01 · FY2025 · NS
Phase 1 Evaluation of Enhanced Natural Killer Cells as a Treatment Strategy in Non-Small cell Lung Cancer Patients Refractory to PD-1/PD-L1 Immune Checkpoint Inhibitors
$358,924Miguel Angel Villalona · University Of California-Irvine · R01 · FY2023 · CA
Targeting Wnt signaling in therapy-resistant ovarian cancer
$358,851Benjamin G Bitler · University Of Colorado Denver · R37 · FY2025 · CA
Project 3 - Targeting CDK4/6 to modulate immunogenicity in gliomas (Wen/Zhao)
$358,834Jean Zhao · Brigham And Women'S Hospital · P50 · FY2020 · CA
CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors - Cures
$358,830Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA